| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Julia A Critchley | Q61014249 |
| P2093 | author name string | Simon Capewell | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| systematic review | Q1504425 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 86-97 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review | |
| P478 | volume | 290 |
| Q46362404 | 'I wouldn't push that further because I don't want to lose her': a multiperspective qualitative study of behaviour change for long-term conditions in primary care |
| Q37419863 | A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study |
| Q37292559 | A Review of Epigenetic Markers of Tobacco and Alcohol Consumption |
| Q38106667 | A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative. |
| Q64116215 | A comparison of the impact of current smoking on 2-year major clinical outcomes of first- and second-generation drug-eluting stents in acute myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry |
| Q38152620 | A conceptual framework for managing modifiable risk factors for cardiovascular diseases in Fiji |
| Q33775530 | A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease |
| Q37069301 | A new diagnosis of asthma or COPD is linked to smoking cessation - the Tromsø study. |
| Q34976766 | A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention |
| Q52299826 | A randomized controlled trial of stage-matched intervention for smoking cessation in cardiac out-patients. |
| Q41490534 | A retrospective cross-sectional study on the association between tobacco smoking and incidence of ST-segment elevation myocardial infarction and cardiovascular risk factors. |
| Q48417124 | A risk table to assist health practitioners assess and prevent the onset of depression in later life |
| Q82957624 | A system dynamics model for planning cardiovascular disease interventions |
| Q33647497 | ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy |
| Q83066075 | Acid-sensing ion channel subtype 3 function and immunolabelling increases in skeletal muscle sensory neurons following femoral artery occlusion |
| Q61777393 | Adaptation or recovery after health shocks? Evidence using subjective and objective health measures |
| Q36330478 | Adherence to varenicline and abstinence rates for quitting smoking in a private health promotion center-based smoking cessation clinic |
| Q90053194 | An evidence-based toolbox for the design and implementation of selective-prevention primary-care initiatives targeting cardio-metabolic disease |
| Q48684191 | An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction |
| Q48580690 | An integrated secondary prevention group programme reduces depression in cardiac patients |
| Q33754385 | Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. |
| Q34621456 | Antielastin autoimmunity in tobacco smoking-induced emphysema |
| Q38757907 | Are Optimism and Cynical Hostility Associated with Smoking Cessation in Older Women? |
| Q43530920 | Are poor health behaviours in anxious and depressed cardiac patients explained by sociodemographic factors? |
| Q43417354 | Association between awareness of harmful effects of smoking and smoking cessation advice provided by hospital chest physicians in Guangzhou, China: a multi-institutional cross-sectional survey |
| Q41574696 | Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography |
| Q55290790 | Association of Co-Morbidity and Treatment with the Complications of Acute Coronary Syndrome in Young Patients Less Than 45 Years. |
| Q36436790 | Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction |
| Q89877491 | Association of prescription opioids and incident cardiovascular risk factors among post-9/11 Veterans |
| Q35619481 | Association of smoking status with health-related outcomes after percutaneous coronary intervention |
| Q24170524 | Associations of depressive symptoms and brachial artery reactivity among police officers |
| Q35902556 | Atherosclerosis: current status of prevention and treatment |
| Q36771086 | Augmented P2X response and immunolabeling in dorsal root ganglion neurons innervating skeletal muscle following femoral artery occlusion |
| Q47576469 | Availability, Sales, and Affordability of Tobacco Cessation Medicines in Kerala, India |
| Q88265281 | Avoiding the Major Causes of Death: Does Childhood Misfortune Reduce the Likelihood of Being Disease Free in Later Life? |
| Q36970128 | Balancing efficacy and safety in treatment with antipsychotics. |
| Q36861465 | Behavior, knowledge, and attitude of surgeons and patients toward preoperative smoking cessation |
| Q33568435 | Behavioral activation for smoking cessation and mood management following a cardiac event: results of a pilot randomized controlled trial |
| Q36764465 | Bradykinin B2 receptor contributes to the exaggerated muscle mechanoreflex in rats with femoral artery occlusion |
| Q37737993 | Brief intervention to promote smoking cessation and improve glycemic control in smokers with type 2 diabetes: a randomized controlled trial |
| Q40240003 | Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland? |
| Q36593266 | Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease |
| Q82343723 | Cardiac rehabilitation after acute myocardial infarction |
| Q37339354 | Cardiac rehabilitation past, present and future: an overview |
| Q46925626 | Cardiology Rx for Change: improving clinical attention to tobacco use and secondhand smoke exposure in cardiology. |
| Q44960238 | Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study |
| Q94037589 | Cardiovascular risk reduction in referrals to outpatient vascular clinics |
| Q51321897 | Causal associations of tobacco smoking with cardiovascular risk factors: a Mendelian randomization analysis of the HUNT Study in Norway. |
| Q34434419 | Central and peripheral cardiovascular changes immediately after waterpipe smoking |
| Q38830052 | Changes in cardiovascular disease risk and behavioural risk factors before the introduction of a health check programme in England |
| Q37001567 | Changes in smoking behavior and adherence to preventive guidelines among smokers after a heart attack |
| Q90314115 | Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood |
| Q30492121 | Chronic coronary artery disease: diagnosis and management |
| Q34464936 | Chronic medical conditions and risk of sepsis |
| Q36157616 | Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study |
| Q34077515 | Cigarette smoking, passive smoking, alcohol consumption, and hearing loss. |
| Q35905568 | Clinical Characteristics and Outcomes of Acute ST-Segment Elevation Myocardial Infarction in Younger Korean Adults. |
| Q36721194 | Clinical Profile and Long-Term Prognostic Factors of a Young Chinese Han Population (≤ 40 Years) Having ST-Segment Elevation Myocardial Infarction. |
| Q35070830 | Clinician's guide to the updated ABCs of cardiovascular disease prevention |
| Q36367843 | Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial |
| Q28217496 | Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000 |
| Q47169317 | Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study. |
| Q35314681 | Contribution of nerve growth factor to upregulation of P2X₃ expression in DRG neurons of rats with femoral artery occlusion |
| Q37344531 | Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men. |
| Q46642637 | Critical limb ischemia |
| Q90048939 | Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction |
| Q35384480 | Current Diagnosis and Management of Erectile Dysfunction |
| Q38610828 | Decision-making using absolute cardiovascular risk reduction and incremental cost-effectiveness ratios: a case study |
| Q37625065 | Design and initial enrollment in the Vascular Physicians Offer and Report (VAPOR) trial |
| Q35567723 | Development of an interactive, Web-delivered system to increase provider-patient engagement in smoking cessation |
| Q34530098 | Diabetes & coronary heart disease: current perspectives |
| Q58769041 | Diet for stroke prevention |
| Q41877868 | Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada |
| Q46082008 | Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease |
| Q47340089 | Effect of Intensive Personalized "5As+5Rs" Intervention on Smoking Cessation in Hospitalized Acute Coronary Syndrome Patients Not Ready to Quit Immediately: A Randomized Controlled Trial |
| Q92840817 | Effect of interactions between LEPR polymorphisms and smoking on coronary artery disease susceptibility |
| Q58751626 | Effect of present versus previous smoking on non-invasive haemodynamics |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q87806074 | Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial |
| Q40388489 | Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial |
| Q39403383 | Effectiveness of a telephone delivered and a face-to-face delivered counseling intervention for smoking cessation in patients with coronary heart disease: a 6-month follow-up |
| Q34269680 | Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description |
| Q28730693 | Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial |
| Q43735709 | Effects of smoking in patients treated with cardiac resynchronization therapy |
| Q33723269 | Effects of the wars on smoking among veterans |
| Q33897433 | Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial |
| Q47554209 | Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial |
| Q53400846 | Electronic Cigarette Prevalence and Patterns of Use in Adults with a History of Cardiovascular Disease in the United States. |
| Q54601041 | Electronic cigarettes: the lesser of two evils, but how much less? |
| Q24632889 | Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study |
| Q37519624 | Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right? |
| Q37179187 | Examining Rowe and Kahn's Concept of Successful Aging: Importance of Taking a Life Course Perspective |
| Q84242169 | Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000 |
| Q36933684 | Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. |
| Q38702402 | Exploring Issues of Comorbid Conditions in People Who Smoke |
| Q38738183 | Factors associated with self-reported diabetes according to the 2013 National Health Survey |
| Q38675802 | Feasibility and acceptability of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in Dutch patients with coronary heart disease |
| Q34357620 | Femoral artery occlusion increases expression of ASIC3 in dorsal root ganglion neurons |
| Q38210417 | Functional properties of vinegar. |
| Q30493320 | General practitioners' perceptions of the effectiveness of medical interventions: an exploration of underlying constructs |
| Q59131985 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 |
| Q51805129 | Hazardous drinking is associated with a lower risk of coronary heart disease: results from a national representative sample. |
| Q43694019 | Health and the need for health promotion in hospital patients. |
| Q28395311 | Health effects of light and intermittent smoking: a review |
| Q44370281 | Health-related outcomes associated with patterns of risk factors in primary care patients |
| Q34051223 | Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study. |
| Q41474871 | Helping smokers with cardiac disease to abstain from tobacco after a stay in hospital |
| Q43063562 | Hospitals with percutaneous coronary intervention capability have greater adherence to established myocardial infarction guidelines |
| Q36689809 | Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations |
| Q35119450 | Identifying opportunities for a medical group to improve outcomes for patients with coronary artery disease and heart failure: an exploratory study |
| Q37396909 | Immunological effects of tobacco smoking in "healthy" smokers |
| Q39213747 | Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study |
| Q49329582 | Impact of Myocardial Revascularization Method on Smoking Cessation: Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention |
| Q34805564 | Impact of cardiovascular calcifications on the detrimental effect of continued smoking on cardiovascular risk in male lung cancer screening participants |
| Q56985406 | Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR |
| Q90160588 | Impact of second-hand smoke exposure followed by cigarette smoking quitting on subsequent risk of coronary heart disease: Evidence from the population-based cohort of Tehran Lipid and Glucose Study (TLGS) |
| Q37572108 | Impact of smoking on health-related quality of Life after percutaneous coronary intervention treated with drug-eluting stents: a longitudinal observational study |
| Q37197102 | Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease |
| Q86501122 | Implementation of Cardiovascular Disease Prevention Guidelines in Clinical Practice-Can We Do Better? |
| Q37313780 | Implementing point of care "e-referrals" in 137 clinics to increase access to a quit smoking internet system: the Quit-Primo and National Dental PBRN HI-QUIT Studies. |
| Q41831369 | In Vitro and Ex Vivo Approaches to Evaluate Next-Generation Tobacco and Non-Tobacco Products on Human Blood Platelets |
| Q33644984 | Income-related inequality in smoking cessation among adult patients with cardiovascular disease: a 5-year follow-up of an angiography intervention in Luxembourg |
| Q52629651 | Index coronary angiography use in Manitoba, Canada: a population-level descriptive analysis of First Nations and non-First Nations recipients. |
| Q36721197 | Influence of Cigarette Smoking on Burden and Characteristics of Coronary Artery Plaques in Chinese Men. |
| Q92289978 | Influence of Smoking Status on Risk of Incident Heart Failure: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
| Q91664784 | Influence of rurality on the awareness of myocardial infarction symptoms in the US |
| Q33604263 | Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis |
| Q36029824 | Interstitial lung disease in lung cancer: separating disease progression from treatment effects. |
| Q82680876 | Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use? |
| Q28266074 | Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies |
| Q34140693 | Is there any association between use of smokeless tobacco products and coronary heart disease in Bangladesh? |
| Q58362346 | Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 |
| Q39691859 | Knowledge of heart disease among women in an urban emergency setting. |
| Q51745545 | Lack of effects of simvastatin on smoking cessation in humans: A double-blind, randomized, placebo-controlled clinical study. |
| Q39332666 | Life Years Gained From Smoking-Cessation Counseling After Myocardial Infarction |
| Q61192550 | Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000 |
| Q35763101 | Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? |
| Q38511050 | Limb ischemia: cardiovascular diagnosis and management from head to toe. |
| Q39097856 | Lipid and other management to improve arterial disease and survival in end stage renal disease |
| Q37619497 | Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges |
| Q33520748 | Living healthier for longer: comparative effects of three heart-healthy behaviors on life expectancy with and without cardiovascular disease |
| Q41688356 | Long-term effect of a low-intensity smoking intervention embedded in an adherence program for patients with hypercholesterolemia: Randomized controlled trial |
| Q49213720 | Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk |
| Q34168779 | Low glomerular filtration rate and risk of stroke: meta-analysis |
| Q38135358 | Managing tobacco use: the neglected cardiovascular disease risk factor |
| Q38116561 | Medical management of critical limb ischaemia: where do we stand today? |
| Q38083007 | Medical management of stable coronary atherosclerosis. |
| Q33998019 | Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention |
| Q45852208 | Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. |
| Q83857234 | Modestly overweight women have vascular endothelial dysfunction |
| Q37600462 | Modifiable cardiovascular disease risk factors among indigenous populations |
| Q35529286 | Modifiable determinants of hearing impairment in adults |
| Q33613200 | Modifying risks to improve outcome in cardiac surgery: An anesthesiologist's perspective |
| Q37254899 | Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes |
| Q36933707 | Mortality after acute myocardial infarction according to income and education |
| Q51502269 | Mortality after myocardial infarction: impact of gender and smoking status. |
| Q38039075 | Muscle afferent receptors engaged in augmented sympathetic responsiveness in peripheral artery disease |
| Q37612229 | Myocardial infarction in the Wisconsin Longitudinal Study: the interaction among environmental, health, social, behavioural and genetic factors |
| Q35062040 | Myocardial infarction in the young adult--retrospective analysis of cases compile at the University Hospital of Dakar |
| Q64355425 | National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients |
| Q85857519 | Nerve Growth Factor, Muscle Afferent Receptors and Autonomic Responsiveness with Femoral Artery Occlusion |
| Q36721910 | Nicotine: A Double-Edged Sword in Atherosclerotic Disease |
| Q36035895 | Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. |
| Q51834956 | Older adults and smoking: Characteristics, nicotine dependence and prevalence of DSM-IV 12-month disorders. |
| Q37151946 | Older smokers could be the strongest supporters for U.S. government regulation of tobacco: a focus group study |
| Q35814427 | PURLs: Counseling is a must with this smoking cessation aid |
| Q55508551 | Paroxysmal Atrial Fibrillation in a Patient on Hemodialysis. |
| Q53538677 | Patient Characteristics Predictive of Cardiac Rehabilitation Adherence. |
| Q35905851 | Patient characteristics associated with receipt of lifestyle behavior advice |
| Q93121060 | Patterns of tobacco use among smokers prior to hospitalization for an acute cardiac event: Use of combusted and non-combusted products |
| Q47136200 | Persistent smoking after a cardiovascular event: A nationwide retrospective study in Korea |
| Q47402668 | Persistent smoking rate after coronary revascularization and factors related to smoking cessation in Turkey. |
| Q40046747 | Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer |
| Q24682494 | Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease |
| Q31039629 | Prediction of cardiovascular events by using non-vascular findings on routine chest CT. |
| Q58825376 | Predictors of Successful Smoking Cessation in a Family Practice-Based Cardiovascular Risk Factor Intervention Program: ‘Real-World’ Experience From the Heartwatch Program |
| Q90356124 | Predictors of engagement in post-discharge quitline counseling among hospitalized smokers |
| Q46740523 | Predictors of smoking cessation in patients admitted for acute coronary heart disease |
| Q64099900 | Prescribing trend in cardiovascular patients at Ethiopian university hospital: The number of medications and implication on the clinical improvement |
| Q30584216 | Prevalence and predictors of patient adherence to health recommendations after acute coronary syndrome: data for targeted interventions? |
| Q44323201 | Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus |
| Q24683910 | Prevalence of alternative forms of tobacco use in a population of young adult military recruits |
| Q37499363 | Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association |
| Q35770938 | Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk |
| Q38730815 | Preventive Interventions for the Second Half of Life: A Systematic Review. |
| Q84491678 | Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats |
| Q37285574 | Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach |
| Q38500893 | Primary and secondary prevention of ischemic heart disease in women |
| Q30933733 | Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison |
| Q36921049 | Promoting smoking cessation during hospitalization for coronary artery disease |
| Q24186549 | Psychosocial interventions for smoking cessation in patients with coronary heart disease |
| Q24242515 | Psychosocial interventions for smoking cessation in patients with coronary heart disease |
| Q55116001 | Purinergic P2X Receptors and Heightened Exercise Pressor Reflex in Peripheral Artery Disease. |
| Q34413007 | Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study |
| Q33451720 | Quittr: The Design of a Video Game to Support Smoking Cessation |
| Q30555484 | Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction. |
| Q35826287 | Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands |
| Q35841446 | Rehabilitation status three months after first-time myocardial infarction. |
| Q53111384 | Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. |
| Q33596624 | Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium |
| Q35337424 | Review of electronic decision-support tools for diabetes care: a viable option for low- and middle-income countries? |
| Q46098769 | Risk Factors for Coronary Artery Disease: Historical Perspectives |
| Q36699164 | Risk factors for cardiovascular disease mortality among 86866 members of the Thai Cohort Study, 2005-2010. |
| Q85055540 | Risk of All-Cause Mortality, Recurrent Myocardial Infarction, and Heart Failure Hospitalization Associated With Smoking Status Following Myocardial Infarction With Left Ventricular Dysfunction |
| Q24628826 | Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis |
| Q36320948 | Role for NGF in augmented sympathetic nerve response to activation of mechanically and metabolically sensitive muscle afferents in rats with femoral artery occlusion |
| Q38147825 | Safety of varenicline in patients with cardiovascular disease |
| Q35234319 | Secondary prevention in the intensive care unit: does intensive care unit admission represent a "teachable moment?". |
| Q34224601 | Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association |
| Q84850268 | Secondary prevention of ischaemic cardiac events |
| Q93501271 | Secondary prevention of ischaemic cardiac events |
| Q37205094 | Share2Quit: Web-Based Peer-Driven Referrals for Smoking Cessation |
| Q38377924 | Smokers and Postcessation Weight Gain After Acute Coronary Syndrome |
| Q42681154 | Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study |
| Q55234384 | Smoking Cessation Ameliorates Microalbuminuria With Reduction of Blood Pressure and Pulse Rate in Patients With Already Diagnosed Diabetes Mellitus. |
| Q58988936 | Smoking Cessation in Long-Term Conditions: Is There “An Opportunity in Every Difficulty”? |
| Q39748304 | Smoking Status at Time of Listing for a Heart Transplant Predicts Mortality on the Waiting List: A Multicenter Prospective Observational Study |
| Q51734356 | Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital. |
| Q33819214 | Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study |
| Q36117613 | Smoking and cardiac rehabilitation participation: Associations with referral, attendance and adherence |
| Q33858836 | Smoking behavior among coronary heart disease patients in Jordan: a model from a developing country |
| Q38401226 | Smoking behavior changes in the early rheumatoid arthritis period and risk of mortality during 36 years of prospective follow-up |
| Q90919140 | Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: Assessing patient interest, confidence, and physician prescribing practices |
| Q48569413 | Smoking cessation and outcome after ischemic stroke or TIA. |
| Q40045648 | Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study |
| Q35746799 | Smoking cessation and weight gain |
| Q36773370 | Smoking cessation for cardiac patients |
| Q38914175 | Smoking cessation in cardiac patients: the influence of action plans, coping plans and self-efficacy on quitting smoking |
| Q35763846 | Smoking cessation interventions following acute coronary syndrome: a missed opportunity? |
| Q40440286 | Smoking cessation interventions for patients with coronary heart disease and comorbidities: an observational cross-sectional study in primary care. |
| Q90379366 | Smoking cessation is related to change in metabolic syndrome onset: A rural cohort study |
| Q37505737 | Smoking cessation pharmacotherapy |
| Q34613937 | Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations |
| Q36317157 | Smoking determines the 10-year (2004-2014) prognosis in patients with Acute Coronary Syndrome: the GREECS observational study |
| Q34309485 | Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study |
| Q47759690 | Smoking status on outcomes after percutaneous coronary intervention. |
| Q40287774 | Smoking, APOE Genotype, and Cognitive Decline: The Rotterdam Study |
| Q36241303 | Smoking, cardiac symptoms, and an emergency care visit: a mixed methods exploration of cognitive and emotional reactions |
| Q21144627 | Social relationships and mortality risk: a meta-analytic review |
| Q79254103 | Starting Earlier to Prevent Heart Disease |
| Q47623627 | Staying a smoker or becoming an ex-smoker after hospitalisation for unstable angina or myocardial infarction |
| Q34390558 | Stopping the cardiovascular disease continuum: Focus on prevention |
| Q34306544 | Strategies to help a smoker who is struggling to quit |
| Q36909266 | Stroke prevention in the high-risk patient |
| Q88181231 | Tackling smoking cessation systematically among inpatients with heart disease |
| Q91729229 | The Association Between Cardiac Rehabilitation Attendance and Hospital Readmission |
| Q64929277 | The Connection Prescription: Using the Power of Social Interactions and the Deep Desire for Connectedness to Empower Health and Wellness. |
| Q36399555 | The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease |
| Q34387692 | The QUIT-PRIMO provider-patient Internet-delivered smoking cessation referral intervention: a cluster-randomized comparative effectiveness trial: study protocol |
| Q35779700 | The Relationship between Smoking and Depression Post-Acute Coronary Syndrome |
| Q47132602 | The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post-recruitment |
| Q50558006 | The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. |
| Q44218072 | The association of active and passive smoking with peripheral arterial disease: results from NHANES 1999-2004. |
| Q35145561 | The association of income with health behavior change and disease monitoring among patients with chronic disease |
| Q51138133 | The burden of disease attributable to smoking in Portugal. |
| Q33772159 | The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction. |
| Q44674276 | The effects of a smoking cessation programme on health-promoting lifestyles and smoking cessation in smokers who had undergone percutaneous coronary intervention |
| Q49821983 | The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records. |
| Q33401729 | The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. |
| Q41544045 | The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction |
| Q37961165 | The optimal male health diet and dietary supplement program |
| Q35565814 | The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income country |
| Q42376797 | The prognostic significance of smoking cessation after acute coronary syndromes: an observational, multicentre study from the Melbourne interventional group registry |
| Q35814892 | The risk and burden of smoking related heart disease mortality among young people in the United States |
| Q47791816 | The role of cost-effectiveness analysis in the development of indicators to support incentive-based behaviour in primary care in England |
| Q37738339 | The role of smoking cessation in the prevention of coronary artery disease |
| Q81526888 | The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome |
| Q46468616 | Therapeutic options for premature coronary artery disease |
| Q87486260 | Time-trend analysis on the Framingham risk score and prevalence of cardiovascular risk factors in patients undergoing percutaneous coronary intervention without prior history of coronary vascular disease over the last 17 years: a study from the Mayo |
| Q36801501 | Tobacco control for anesthesiologists |
| Q38305592 | Treating complexity: collaborative care for multiple chronic conditions |
| Q35322312 | Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys |
| Q35969909 | Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region |
| Q46316141 | UK health performance: findings of the Global Burden of Disease Study 2010. |
| Q64106057 | Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease |
| Q37312351 | Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons. |
| Q35685360 | Valued Life Activities, Smoking Cessation, and Mood in Post-Acute Coronary Syndrome Patients. |
| Q26830506 | Varenicline and cardiovascular adverse events: a perspective review |
| Q36842193 | Varenicline in the treatment of tobacco dependence |
| Q35116329 | Web-based peer-driven chain referrals for smoking cessation |
| Q57103063 | What Are the Net Benefits of Reducing the Ozone Standard to 65 ppb? An Alternative Analysis |
| Q36834216 | Who participates in Web-assisted tobacco interventions? The QUIT-PRIMO and National Dental Practice-Based Research Network Hi-Quit studies |
| Q53730280 | [Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies]. |
| Q82834419 | [Risk factor "smoking" : smoking cessation in patients with cardiovascular diseases] |
| Q84391428 | [Working with our smoker patients in primary care. Analysis of cost-effectiveness] |
Search more.